Sofimac Innovation
21
8M
19
0.81
3
0.10
1
- Areas of investment
Summary
In 1998 was created Sofimac Innovation, which is appeared as VC.
The fund has no exact preference in some founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Among the most popular portfolio startups of the fund, we may highlight Exeliom, Igyxos, eLichens. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are Electronics, Information Technology.
The fund is constantly included in 2-6 deals per year. The common things for fund are deals in the range of 10 - 50 millions dollars. The real fund results show that this VC is 9 percentage points less often commits exit comparing to other companies. The top activity for fund was in 2018.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Sofimac Innovation, startups are often financed by Sofimac Partners, Cru00e9dit Agricole, Bpifrance. The meaningful sponsors for the fund in investment in the same round are Bpifrance, Cemag Invest, BNP Paribas Du00e9veloppement. In the next rounds fund is usually obtained by EASME - EU Executive Agency for SMEs.
Investments analytics
Analytics
- Total investments
- 21
- Lead investments
- 3
- Exits
- 1
- Rounds per year
- 0.81
- Follow on index
- 0.10
- Investments by industry
- Software (5)
- Health Care (4)
- Electronics (3)
- Industrial (3)
- Biotechnology (3) Show 35 more
- Investments by region
-
- France (18)
- United States (1)
- The Netherlands (2)
- Peak activity year
- 2021
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 7
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| ELWAVE | 20 Jan 2021 | Robotics, Manufacturing, Semiconductor, Industrial | Seed | 2M | Zuid-Holland, Delft, The Netherlands |
| Igyxos | 21 Mar 2019 | Biotechnology, Pharmaceutical | Early Stage Venture | 8M | France, Centre-Loire Valley |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.